Skip to Main Content

Paper Details

CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma.
Thorac Cancer
2
2023
38 type B3, CAGE, CALML5, CALML5 genes, Thymic squamous cell carcinoma, cytoplasm, primary neoplasms of the anterior mediastinum, thymic carcinoma, thymic carcinomas, thymic squamous cell carcinoma, thymomas, type B3 thymoma, type B3 thymomas
Author NameAffiliation
Masayoshi Itoh
Masayoshi ItohRIKEN Center for Integrative Medical Sciences
Masayoshi Itoh
Masayoshi ItohRIKEN Center for Integrative Medical Sciences
Hideya Kawaji
Hideya KawajiRIKEN Advanced Center for Computing and Communication
Hideya KawajiResearch Center for Genome & Medical Sciences, Tokyo Metropolitan Institute of Medical Science
Hideya Kawaji
Hideya KawajiRIKEN Advanced Center for Computing and Communication
Hideya KawajiResearch Center for Genome & Medical Sciences, Tokyo Metropolitan Institute of Medical Science
  • 1 - 10

Datasets

Release 1.2